Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study
Primary Purpose
in Situ Breast Cancer, Invasive Breast Cancer
Status
Unknown status
Phase
Phase 3
Locations
Hungary
Study Type
Interventional
Intervention
Insertion of suction drain(s) following mastectomy
Adaptive skin sutures.
Sponsored by
About this trial
This is an interventional health services research trial for in Situ Breast Cancer focused on measuring simple mastectomy, modified radical mastectomy, wound care, suction drain, adaptive suture
Eligibility Criteria
Inclusion Criteria:
- female patients with primary unilateral, stage 0, I or II, T3N1M0 breast cancer necessitating simple or modified radical mastectomy
Exclusion Criteria:
- age above 75 years and bad general state
- pregnancy
- autoimmune disease
- non-radical excision
- mastitis carcinomatosis
- lymphangitis carcinomatosis
- wound infection necessitating treatment
Sites / Locations
- National Institute of OncologyRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Suction drain
Adaptive suture
Arm Description
Patients in Arm A undergo simplex mastectomy or modified radical mastectomy. One plastic Redon drain (16 Ch) is placed after simplex mastectomy and two plastic Redon drains (16 Ch each) following modified radical mastectomy.
Following mastectomy, wound cavity is closed with adaptive skin sutures. No suction drain is inserted.
Outcomes
Primary Outcome Measures
Total amount of sera withdrawn from the wound cavity
By each follow-up visit within the indicated time frame, the punctuated serum is collected and its volume is measured by a measuring cylinder acquired from the Pharmacy Department and data is recorded. At the end of the follow-up period, the total amount of serum (mL) is documented.
Secondary Outcome Measures
Extent of early postoperative analgesic requirements
Assessment of analgesic consumption to achieve adequate pain relief for each patient. Pain relief is carried out according to institutional protocol and includes: diclofenac sodium, diclofenac sodium + orphenadrine, nalbuphine, metamizole sodium, paracetamole, tramadole.
Number of punctions following the removal of suction drain, and total volume of punctuated seroma (mL)
Rate of local wound complications.
Assessment of quality of life in the early postoperative period
Using EORTC QoL BR23, weekly for 4 weeks following surgery.
Mobility of the shoulder on the side of the operated side
Assessing shoulder motion on the 1st postoperative day, then weekly for 4 weeks.
Abduction 1: 0°- 45° Abduction 2: 45° - 90° Abduction 3: 90° - 135° Abduction 4: 135° - 180°
Cost analysis
Suction drain, suction flask, syringes, number of patient-doctor consultations
Full Information
NCT ID
NCT01509781
First Posted
January 8, 2012
Last Updated
October 5, 2015
Sponsor
National Institute of Oncology, Hungary
1. Study Identification
Unique Protocol Identification Number
NCT01509781
Brief Title
Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study
Official Title
Optimal Wound Care After Simplex or Modified Radical Mastectomy With or Without Axillary Lymphadenectomy Placement of a Drain Versus the Use of Adaptive Skin Sutures; a Prospective Randomised Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2015
Overall Recruitment Status
Unknown status
Study Start Date
September 2011 (undefined)
Primary Completion Date
January 2016 (Anticipated)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Institute of Oncology, Hungary
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The objective of this prospective randomized study is to perform qualitative and quantitative comparisons between the insertion of traditional suction drains (Arm: Suction drain) versus the application of absorbable adaptive sutures (Arm: Adaptive suture) following simplex mastectomy or modified radical mastectomy in the light of the total volume of withdrawn serum from wound cavity, the extent of early postoperative analgesic requirements and quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
in Situ Breast Cancer, Invasive Breast Cancer
Keywords
simple mastectomy, modified radical mastectomy, wound care, suction drain, adaptive suture
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
400 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Suction drain
Arm Type
Active Comparator
Arm Description
Patients in Arm A undergo simplex mastectomy or modified radical mastectomy. One plastic Redon drain (16 Ch) is placed after simplex mastectomy and two plastic Redon drains (16 Ch each) following modified radical mastectomy.
Arm Title
Adaptive suture
Arm Type
Experimental
Arm Description
Following mastectomy, wound cavity is closed with adaptive skin sutures. No suction drain is inserted.
Intervention Type
Procedure
Intervention Name(s)
Insertion of suction drain(s) following mastectomy
Intervention Description
One suction drain (16 Ch Redon drain) following simple mastectomy and two following modified radical mastectomy.
Intervention Type
Procedure
Intervention Name(s)
Adaptive skin sutures.
Intervention Description
Subcutis of skin flaps of the axilla and the wound edges are adapted to the chest wall and pectoralis major muscle by 8 to 24 stitches (depending on the wound surface of the breast and axilla) using 3.0 absorbable sutures, in a distance of 4-5 cm from each other in a chessboard pattern. The wound is then closed with 3.0 running subcutaneous sutures and 4.0 intracutaneous stitches. Compressive dressing is applied on the chest in the first 12-24 hours after surgery.
Primary Outcome Measure Information:
Title
Total amount of sera withdrawn from the wound cavity
Description
By each follow-up visit within the indicated time frame, the punctuated serum is collected and its volume is measured by a measuring cylinder acquired from the Pharmacy Department and data is recorded. At the end of the follow-up period, the total amount of serum (mL) is documented.
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
Extent of early postoperative analgesic requirements
Description
Assessment of analgesic consumption to achieve adequate pain relief for each patient. Pain relief is carried out according to institutional protocol and includes: diclofenac sodium, diclofenac sodium + orphenadrine, nalbuphine, metamizole sodium, paracetamole, tramadole.
Time Frame
4 days
Title
Number of punctions following the removal of suction drain, and total volume of punctuated seroma (mL)
Time Frame
4 weeks
Title
Rate of local wound complications.
Time Frame
4 weeks
Title
Assessment of quality of life in the early postoperative period
Description
Using EORTC QoL BR23, weekly for 4 weeks following surgery.
Time Frame
4 weeks
Title
Mobility of the shoulder on the side of the operated side
Description
Assessing shoulder motion on the 1st postoperative day, then weekly for 4 weeks.
Abduction 1: 0°- 45° Abduction 2: 45° - 90° Abduction 3: 90° - 135° Abduction 4: 135° - 180°
Time Frame
4 weeks
Title
Cost analysis
Description
Suction drain, suction flask, syringes, number of patient-doctor consultations
Time Frame
4 weeks
10. Eligibility
Sex
Female
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
female patients with primary unilateral, stage 0, I or II, T3N1M0 breast cancer necessitating simple or modified radical mastectomy
Exclusion Criteria:
age above 75 years and bad general state
pregnancy
autoimmune disease
non-radical excision
mastitis carcinomatosis
lymphangitis carcinomatosis
wound infection necessitating treatment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Zoltan Matrai, M.D.
Phone
+36 1 224 8600
Ext
3302
Email
matraidoc@gmail.hu
First Name & Middle Initial & Last Name or Official Title & Degree
Laszlo Toth, M.D., Ph.D.
Email
toth.l@oncol.hu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Miklos Kasler, M.D., Ph.D., D.Sc., Prof.
Organizational Affiliation
National Institute of Oncology
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Laszlo Toth, M.D., Ph.D., Prof.
Organizational Affiliation
National Institute of Oncology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ferenc Renyi Vamos, M.D., Ph.D.
Organizational Affiliation
National Institute of Oncology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Akos Savolt, M.D.
Organizational Affiliation
National Institute of Oncology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Emil Farkas, M.D.
Organizational Affiliation
National Institute of Oncology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Ildiko Horti, M.D.
Organizational Affiliation
National Institute of Oncology
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Zoltan Matrai, M.D.
Organizational Affiliation
National Institute of Oncology
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Institute of Oncology
City
Budapest
ZIP/Postal Code
1122
Country
Hungary
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zoltan Matrai, M.D.
Phone
+3612248600
Ext
3302
Email
matraidoc@gmail.com
12. IPD Sharing Statement
Learn more about this trial
Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study
We'll reach out to this number within 24 hrs